President Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...

Glenmark Pharmaceuticals' shares surged following its subsidiary's $700 million upfront payment from AbbVie for an exclusive licensing agre...

S&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVi...

Glenmark Pharma surged 14% after its subsidiary signed a $700 million licensing deal with AbbVie for its experimental cancer drug, ISB 2001...

Glenmark Pharma Share Price: Glenmark Pharmaceuticals' shares soared after its subsidiary, Ichnos Glenmark Innovation, inked a global licen...

Glenmark Pharmaceuticals has entered into a significant agreement with AbbVie to commercialize its investigational drug, ISB 2001, targetin...

India's Department of Pharmaceuticals found AbbVie Healthcare India sponsored ₹1.91 crore in international trips for 30 doctors, violating ...

The National Medical Commission has launched an investigation into doctors whose foreign trips, funded by AbbVie Healthcare, breached the U...

AbbVie Healthcare India has denied accusations of unethical marketing by the Department of Pharmaceuticals, asserting their compliance with...

The department of pharmaceuticals (DoP) reprimanded AbbVie Healthcare India for unethical marketing practices involving over ₹1 crore spent...

Novartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceuticals maker said on Wednesday, after...

The company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...

In addition, the drug maker is also considering making India part of its global Phase-3 clinical trials for potential therapies under devel...

Sharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...

Additionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the...

The approval for trandolapril and verapamil hydrochloride extended release tablets has been granted to Glenmark Generics Inc.

US-based drug maker AbbVie Inc has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six count...